Sophia Genetics Sa (SOPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -61,270 | -46,728 | -28,420 | -13,388 | -78,495 |
| Depreciation Amortization | 8,596 | 6,309 | 4,096 | 2,059 | 8,336 |
| Accounts receivable | 5,892 | 3,813 | 3,042 | 2,168 | -6,500 |
| Accounts payable and accrued liabilities | -7,385 | -4,822 | -6,100 | -4,058 | 6,871 |
| Other Working Capital | -3,117 | -1,381 | -2,779 | -1,697 | 872 |
| Other Operating Activity | 12,769 | 8,980 | 5,099 | 271 | 20,341 |
| Operating Cash Flow | $-44,515 | $-33,829 | $-25,062 | $-14,645 | $-48,575 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 17,546 |
| PPE Investments | -244 | -187 | -111 | -99 | -1,494 |
| Purchase Of Investment | N/A | N/A | N/A | 953 | N/A |
| Purchase Sale Intangibles | -195 | -195 | -167 | -50 | -263 |
| Other Investing Activity | -4,511 | -3,308 | -2,009 | -1,859 | -7,732 |
| Investing Cash Flow | $-4,755 | $-3,495 | $-2,120 | $-1,005 | $8,320 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 13,930 | 13,930 | 13,930 | N/A | N/A |
| Common Stock Issued | 405 | 370 | 298 | 188 | 226 |
| Other Financing Activity | -4,478 | -3,275 | -2,049 | -931 | -3,043 |
| Financing Cash Flow | $9,857 | $11,025 | $12,179 | $-743 | $-2,817 |
| Exchange Rate Effect | -3,612 | -1,165 | -2,852 | -3,123 | 5,018 |
| Beginning Cash Position | 123,251 | 123,251 | 123,251 | 123,251 | 161,305 |
| End Cash Position | 80,226 | 95,787 | 105,396 | 103,735 | 123,251 |
| Net Cash Flow | $-43,025 | $-27,464 | $-17,855 | $-19,516 | $-38,054 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,515 | -33,829 | -25,062 | -14,645 | -48,575 |
| Capital Expenditure | -244 | -187 | -111 | -99 | -1,494 |
| Free Cash Flow | -44,759 | -34,016 | -25,173 | -14,744 | -50,069 |